Abstract
Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables including raspberries, strawberries, cranberries, walnuts, pecans, pomegranates and other plant foods. The antiproliferative and antioxidant properties of ellagic acid have spurred several researches into the potential health benefits of its consumption, leading to its marketing as a dietary supplement. Recently, ellagic acid was shown to display interesting and usable antimalarial activity. However, the relatively insolubility of this compound in water and organic solvents, and its low bioavailability tend to disqualify it as a potential drug candidate. In this review, we will discuss the potential of ellagic acid and derivatives as antimalarial drug candidates. While highlighting their numerous biological and pharmacological activities against other human ailments, we will evaluate the possibility of developing this family of compounds as antimalarial drugs, and discuss strategies and related challenges to achieve that goal.
Keywords: Ellagic acid and derivatives, synthesis, antimalarial activity, other biological and pharmacological properties
Current Bioactive Compounds
Title: The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate
Volume: 6 Issue: 3
Author(s): Jean Fotie
Affiliation:
Keywords: Ellagic acid and derivatives, synthesis, antimalarial activity, other biological and pharmacological properties
Abstract: Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables including raspberries, strawberries, cranberries, walnuts, pecans, pomegranates and other plant foods. The antiproliferative and antioxidant properties of ellagic acid have spurred several researches into the potential health benefits of its consumption, leading to its marketing as a dietary supplement. Recently, ellagic acid was shown to display interesting and usable antimalarial activity. However, the relatively insolubility of this compound in water and organic solvents, and its low bioavailability tend to disqualify it as a potential drug candidate. In this review, we will discuss the potential of ellagic acid and derivatives as antimalarial drug candidates. While highlighting their numerous biological and pharmacological activities against other human ailments, we will evaluate the possibility of developing this family of compounds as antimalarial drugs, and discuss strategies and related challenges to achieve that goal.
Export Options
About this article
Cite this article as:
Fotie Jean, The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate, Current Bioactive Compounds 2010; 6 (3) . https://dx.doi.org/10.2174/157340710793237344
DOI https://dx.doi.org/10.2174/157340710793237344 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design Novel Anticancer Agents and Targets: Recent Advances and Future Perspectives
Mini-Reviews in Medicinal Chemistry Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Organosulfur Compounds in Cancer Chemoprevention
Mini-Reviews in Medicinal Chemistry Radiation-Induced Bystander and other Non-Targeted Effects: Novel Intervention Points in Cancer Therapy?
Current Cancer Drug Targets Leucine-zipper and Sterile-α Motif Kinase (ZAK): A Potential Target for Drug Discovery
Current Medicinal Chemistry The Epidemiology of Sepsis
Current Pharmaceutical Design Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
Current Drug Metabolism MIIP, a Cytoskeleton Regulator that Blocks Cell Migration and Invasion, Delays Mitosis, and Suppresses Tumorogenesis
Current Protein & Peptide Science Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology New Antimicrobial Frontiers
Mini-Reviews in Medicinal Chemistry Innovations and Improvements in Pharmacokinetic Models Based on Physiology
Current Drug Delivery Extracellular Citrate in Health and Disease
Current Molecular Medicine Probiotics in the Prevention of Urogenital Tract Infections. Mechanisms Involved
Current Women`s Health Reviews Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets
Current Topics in Medicinal Chemistry Recent Development of Copolymeric Delivery System for Anticancer Agents Based on Cyclodextrin Derivatives
Anti-Cancer Agents in Medicinal Chemistry Dual Role of Heat Shock Proteins (HSPs) in Anti-Tumor Immunity
Current Molecular Medicine The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Nanocarriers for Gene Delivery - Polymer Structure, Targeting Ligands and Controlled-Release Devices
Current Nanoscience Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy